Meier-Kriesche Herwig-Ulf, Kaplan Bruce
Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, USA.
Transplantation. 2002 Nov 27;74(10):1377-81. doi: 10.1097/00007890-200211270-00005.
Waiting time on dialysis has been shown to be associated with worse outcomes after living and cadaveric transplantation. To validate and quantify end-stage renal disease (ESRD) time as an independent risk factor for kidney transplantation, we compared the outcome of paired donor kidneys, destined to patients who had ESRD more than 2 years compared to patients who had ESRD less than 6 months.
We analyzed data available from the U.S. Renal Data System database between 1988 and 1998 by Kaplan-Meier estimates and Cox proportional hazards models to quantify the effect of ESRD time on paired cadaveric kidneys and on all cadaveric kidneys compared to living-donated kidneys.
Five- and 10-year unadjusted graft survival rates were significantly worse in paired kidney recipients who had undergone more than 24 months of dialysis (58% and 29%, respectively) compared to paired kidney recipients who had undergone less than 6 months of dialysis (78% and 63%, respectively; P<0.001 each). Ten-year overall adjusted graft survival for cadaveric transplants was 69% for preemptive transplants versus 39% for transplants after 24 months on dialysis. For living transplants, 10-year overall adjusted graft survival was 75% for preemptive transplants versus 49% for transplants after 24 month on dialysis.
ESRD time is arguably the strongest independent modifiable risk factor for renal transplant outcomes. Part of the advantage of living-donor versus cadaveric-donor transplantation may be explained by waiting time. This effect is dominant enough that a cadaveric renal transplant recipient with an ESRD time less than 6 months has the equivalent graft survival of living donor transplant recipients who wait on dialysis for more than 2 years.
透析等待时间已被证明与活体及尸体肾移植后的不良预后相关。为了验证并量化终末期肾病(ESRD)时间作为肾移植独立危险因素的作用,我们比较了配对供肾给予ESRD超过2年患者与ESRD少于6个月患者的移植结局。
我们通过Kaplan-Meier估计法和Cox比例风险模型分析了1988年至1998年美国肾脏数据系统数据库中的可用数据,以量化ESRD时间对配对尸体肾以及与活体供肾相比的所有尸体肾的影响。
透析超过24个月的配对肾受者的5年和10年未调整移植物存活率(分别为58%和29%)显著低于透析少于6个月的配对肾受者(分别为78%和63%;每项P<0.001)。尸体肾移植的10年总体调整移植物存活率,抢先移植为69%,透析24个月后移植为39%。对于活体肾移植,抢先移植的10年总体调整移植物存活率为75%,透析24个月后移植为49%。
ESRD时间可以说是肾移植结局最强的独立可改变危险因素。活体供肾移植与尸体供肾移植相比的部分优势可能可以用等待时间来解释。这种影响足够显著,以至于ESRD时间少于6个月的尸体肾移植受者的移植物存活率与透析等待超过2年的活体供肾移植受者相当。